This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nuvilex's Subsidiary Files International Patent For All-Natural Flu Virus Treatment

SILVER SPRING, Md., Jan. 15, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing natural products and cell and gene therapy solutions for the treatment of human diseases, announced today its subsidiary, KnockOut Technologies, Ltd., has filed a patent in Thailand for all-natural product formulations and their potential use in preventing and treating infections caused by influenza viruses.

The initial patent application was filed in January of 2008 and after a lengthy review process it was resubmitted to patent officials in Thailand by our counsel this week. The all-natural formulations described in the patent have the potential to impact upon outbreaks of influenza virus infections. Thailand was chosen for submission of this patent in 2008 as a result of endemic influenza in that region. 

"Seasonal" influenza (flu) is an acute viral infection that can affect all age groups, but children under two years of age, adults over 65, and those with weakened immune systems or with other serious illnesses such as diabetes, chronic heart, lung, and liver diseases, are at the highest risk. According to the World Health Organization (WHO), annual epidemics of seasonal flu result in about 3-5 million cases of severe illness and about 250,000-500,000 deaths worldwide. 

The natural patent formulations contain a mixture of orange oils. In standard laboratory tests used to determine antiviral activity, our formulations containing these ingredients were shown to be effective in killing these flu viruses. 

We believe acceptance of this patent represents an important step in the development of all-natural anti-viral formulations that will ultimately lead to approval by regulatory authorities for the sale of one or more products. Nuvilex has been planning to continue to expand its present work with groups in Thailand to aid in combating viruses particularly in Southeast Asia. The Company hopes to receive approval of the patent within 90-180 days.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs